Alexander O Pasternak
Overview
Explore the profile of Alexander O Pasternak including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
42
Citations
1181
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dorman A, Bendoumou M, Valaitiene A, Wadas J, Ali H, Dutilleul A, et al.
Nat Commun
. 2025 Feb;
16(1):2078.
PMID: 40021667
HIV-1 latency is mainly characterized at transcriptional level, and little is known about post-transcriptional mechanisms and their contribution to reactivation. The viral protein Rev controls the nucleocytoplasmic export of unspliced...
2.
van Paassen P, Boyd A, Pasternak A, Maurer I, Harskamp A, Grijsen M, et al.
AIDS
. 2025 Feb;
PMID: 39951015
Objective: After analytical treatment interruption (ATI), viral rebound occurs in most people with HIV. The time to viral rebound (TTVR) is likely determined by the properties of the viral reservoir...
3.
Chen W, Berkhout B, Pasternak A
Curr HIV/AIDS Rep
. 2025 Feb;
22(1):15.
PMID: 39903363
Purpose Of Review: Despite suppressive antiretroviral therapy (ART), HIV-1 reservoirs persist in various cell types and tissues and reignite active replication if therapy is stopped. Persistence of the viral reservoirs...
4.
Giron L, Pasternak A, Abdel-Mohsen M
Curr Opin HIV AIDS
. 2024 Oct;
20(1):61-69.
PMID: 39392413
Purpose Of Review: We focus on the different classes of biological molecules measurable in easily accessible bodily fluids that have the potential to serve as biomarkers for the HIV post-treatment...
5.
Fombellida-Lopez C, Berkhout B, Darcis G, Pasternak A
Curr Opin HIV AIDS
. 2024 Mar;
19(3):124-132.
PMID: 38502547
Purpose Of Review: Despite suppressive antiretroviral therapy (ART), HIV-1 reservoirs persist and reignite viral replication if therapy is interrupted. Persistence of the viral reservoir in people with HIV-1 (PWH) is...
6.
Pasternak A, Tsukamoto T, Berkhout B
AIDS
. 2023 Oct;
37(14):2239-2241.
PMID: 37877277
No abstract available.
7.
Pasternak A, Rohr O, Van Lint C, Kula-Pacurar A
Front Cell Infect Microbiol
. 2023 May;
13:1213356.
PMID: 37249980
[This corrects the article DOI: 10.3389/fcimb.2023.1190867.].
8.
Riechert V, Hein S, Visser M, Zimmermann M, Wesche J, Adams P, et al.
J Biol Chem
. 2023 Apr;
299(6):104743.
PMID: 37100283
Fc receptors are involved in a variety of physiologically and disease-relevant responses. Among them, FcγRIIA (CD32a) is known for its activating functions in pathogen recognition and platelet biology, and, as...
9.
Pasternak A, Rohr O, Van Lint C, Kula-Pacurar A
Front Cell Infect Microbiol
. 2023 Apr;
13:1190867.
PMID: 37077527
No abstract available.
10.
Pasternak A, Berkhout B
Curr Opin Virol
. 2023 Feb;
59:101301.
PMID: 36805974
Despite decades of suppressive antiretroviral therapy, human immunodeficiency virus (HIV) reservoirs in infected individuals persist and fuel viral rebound once therapy is interrupted. The persistence of viral reservoirs is the...